Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jacob Chacko

CEO, President at Oric Pharmaceuticals, Inc. (ORIC)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.8M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 17SEC ORICOric Pharmaceuticals, Inc. Sell 33,374581,711 held (−5%) $9.06 $302K +36.3%
Oct 8SEC ORICOric Pharmaceuticals, Inc. Sell Plan 37,461531,419 held (−7%) $12.32 $462K +0.2%
Oct 2SEC ORICOric Pharmaceuticals, Inc. Sell Plan 34,538621,881 held (−5%) $12.01 $415K +2.8%
Oct 2SEC ORICOric Pharmaceuticals, Inc. Sell Plan 53,001568,880 held (−9%) $12.05 $639K +2.5%
  • Sell

    CEO, President Jacob Chacko sold $462K of ORIC at $12.32 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Jacob Chacko sold $415K of ORIC at $12.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Jacob Chacko sold $639K of ORIC at $12.05 — pre-scheduled 10b5-1 plan sale.